Medical device manufacturer AngioDynamics’ (ANGO) third quarter 2018 revenue fell short of consensus estimate. The company’s revenue dropped 2.1% year-over-year, while the
AngioDynamics misses Q3 revenue expectation; reports double digit earnings growth
